Navigation Links
Reportlinker Adds Medical Enzymes: Technologies and Global Markets
Date:5/3/2011

NEW YORK, May 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Medical Enzymes: Technologies and Global Markets

http://www.reportlinker.com/p0488650/Medical-Enzymes-Technologies-and-Global-Markets.html

The market for enzymes in medicine is growing. The global market for medical enzymes is estimated at $6 billion in 2010. The market is growing at a compound annual growth rate (CAGR) of 3.9%, to reach $7.2 billion in 2015.

Therapeutic enzymes are the biggest segment in terms of revenues generated. This sector was valued at $5.3 billion in 2010 and is expected to increase at a 3.6% compound annual growth rate (CAGR) to reach $6.3 billion in 2015.

Enzymes used in molecular research will experience the fastest compound annual growth rate (CAGR), 6.2%, over the study period. This sector was worth $546 million in 2010 and should reach nearly $739 million by 2015. 

INTRODUCTION

STUDY GOAL OBJECTIVES

BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical enzymes. The key objective is to present a comprehensive analysis of the current market and its future direction as an important tool for increasing the efficiency and specificity of the products in which medical enzymes are used.

This report explores present and future strategies within the medical enzymes market, which includes the therapeutic, diagnostics, and molecular research sector. The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. The nomenclature, history, and the classification of different types of enzymes are also discussed.

A detailed analysis of the structure of the medical enzymes industry has been conducted. Revenues are broken down by global region. Sales figures are estimated for the 5-year period from 2010 through 2015.

Applications or the uses of medical enzymes are also discussed separately in the report, with emphasis on the usage in various disease sectors. The report also covers the usage of enzymes for diagnostic purposes and in molecular research like sequencing, mapping, and so on. The report also covers significant patents and their number in each category.

REASONS FOR DOING THIS STUDY

A rapid increase in enzyme knowledge has resulted in harvesting the advantages of enzymes in almost every field of life. Enzymes are not only used for industrial purposes but also are used in various fields of the healthcare industry including therapeutics, diagnostics, and molecular research.

Modern industries have now begun to explore the advantages of enzymes in their production processes. This has led to a growing market for enzymes. Genetic engineering technology has made it possible to produce the enzymes in a form identical to the one that normally takes place in the human body.

The increasing competition, patent expirations, and new technologies are taking this industry in a new direction. Although the industry did see a setback in 2009 due to some manufacturing problems and FDA regulations, new advancements and increased spending in research and development are causing the market to grow. This study looks at almost all of the systems affected by these factors.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type of technology in light of the new technologies, growing competition, and changing customer needs.

CONTRIBUTIONS of THE STUDY AND ITS INTENDED AUDIENCE

This study contributes to the areas of market growth in therapeutic, diagnostic, and research enzyme manufacturers and users. Pharmaceutical, chemical, biochemical, and biotechnical companies, industries, and research institutes will find this study to be of interest.

SCOPE of THE STUDY

The scope of this study encompasses medical or medicinal enzymes, bio-technical, pharmaceutical, and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various chemical, biotechnical, food and beverages, and technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

CHAPTER ONE: INTRODUCTION

STUDY GOAL OBJECTIVES

REASONS FOR DOING THIS STUDY

CONTRIBUTIONS OF THE STUDY AND ITS INTENDED AUDIENCE

SCOPE OF THE STUDY

METHODOLOGY

INFORMATION SOURCES

ANALYSTS' CREDENTIALS

RELATED BCC RESEARCH REPORTS

BCC ONLINE SERVICES

DISCLAIMER

CHAPTER TWO: EXECUTIVE SUMMARY

EXECUTIVE SUMMARY

SUMMARY TABLE WORLDWIDE REVENUE OF MEDICAL ENZYMES MARKET, THROUGH 2015 ($ MILLIONS)

SUMMARY FIGURE WORLDWIDE REVENUE OF MEDICAL ENZYMES MARKET, 2010 AND 2015 ($ MILLIONS)

CHAPTER THREE: OVERVIEW

DEFINITIONS

STRUCTURE OF ENZYMES

ACTIVATION ENERGY

SPECIFICITY

ENZYME SUBSTRATE INTERACTION

CONDITIONS OF ENZYME ACTION

NOMENCLATURE OF ENZYMES

HISTORY OF ENZYMES

CLASSIFICATION

OXIDOREDUCTASES

TRANSFERASES

HYDROLASES

LYASES

ISOMERASES

LIGASES

REAL-LIFE APPLICATIONS OF ENZYMES

METABOLIC ENZYMES

DIGESTIVE ENZYMES

FOOD ENZYMES

THE HUMAN BODY NEEDS ENZYMES

ENZYMES IN MEDICINE

TABLE 1 EXAMPLES OF ENZYMES, THEIR SOURCES AND REACTIONS THEY CATALYZE

THERAPEUTIC ENZYMES

Enzyme Therapy

TABLE 2 THERAPEUTIC ENZYMES

Asparaginase

Collagenase

Glutaminase

Hyaluronidase

Beta-Lactamase

Rhodanase

Streptokinase

Trypsin

Uricase

Urokinase

DIAGNOSTIC ENZYMES

Catalase

Cholesterol Esterase (CE)

Glucose Oxidase

Horseradish Peroxidase

Xanthine Oxidase

TABLE 3 DIAGNOSTIC ENZYMES

ENZYMES FOR BIOMEDICAL RESEARCH

Lysozyme

Micrococcal Nuclease

Taq DNA Polymerase

Recombinant HIV Reverse Transcriptase

TABLE 4 BIOMEDICAL ENZYMES

CHAPTER FOUR: CLASSIFICATION OF ENZYMES

CLASSIFICATION OF MEDICAL ENZYMES

THERAPEUTIC ENZYMES

DIGESTIVE ENZYMES

TABLE 5 PANCREATIC ENZYME PRODUCTS

LYSOSOMAL ENZYMES

TABLE 6 LYSOSOMAL ENZYME PRODUCTS

THROMBOLYTIC ENZYMES

TABLE 7 THROMBOLYTIC ENZYME PRODUCTS

OTHER ENZYMES

TABLE 8 OTHER ENZYME PRODUCTS

DIAGNOSTIC ENZYMES

OXIDOREDUCTASES

TABLE 9 EXAMPLES OF OXIDOREDUCTASE

HYDROLASES

TABLE 10 EXAMPLES OF HYDROLASES

TRANSFERASES

TABLE 11 EXAMPLES OF TRANSFERASES

LYASES

TABLE 12 EXAMPLES OF LYSASES

ENZYMES FOR BIOMEDICAL RESEARCH

LYSING ENZYMES

TABLE 13 EXAMPLES OF LYSING ENZYMES

CLEAVING ENZYMES

TABLE 14 EXAMPLES OF CLEAVING ENZYMES

SYNTHESIZING ENZYMES

TABLE 15 EXAMPLES OF SYNTHESIZING ENZYMES

JOINING ENZYMES

TABLE 16 EXAMPLES OF JOINING ENZYMES

ALKALINE PHOSPHATASE

TABLE 17 EXAMPLES OF ALKALINE PHOSPHATASE ENZYMES

CHAPTER FIVE: REGULATORY ASPECTS

REGULATORY ASPECTS

TABLE 18 NEW APPROVALS FOR THERAPEUTIC ENZYMES

TABLE 19 NEW DRUG APPLICATIONS FOR THERAPEUTIC ENZYMES

CHAPTER SIX: INDUSTRY STRUCTURE

MANUFACTURERS/ SUPPLIERS FOR THERAPEUTIC ENZYMES

DIGESTIVE ENZYME PRODUCTS/PANCREATIC ENZYME PRODUCTS

TABLE 20 LEADING MANUFACTURERS/SUPPLIERS OF DIGESTIVE ENZYME PRODUCTS/PANCREATIC ENZYME PRODUCTS

LYSOSOMAL ENZYME PRODUCTS

TABLE 21 LEADING MANUFACTURERS/SUPPLIERS OF LYSOSOMAL ENZYME PRODUCTS

THROMBOLYTIC ENZYME PRODUCTS

TABLE 22 LEADING MANUFACTURERS/SUPPLIERS OF THROMBOLYTIC ENZYME PRODUCTS

OTHER THERAPEUTIC ENZYMES

TABLE 23 LEADING MANUFACTURERS/SUPPLIERS OF OTHER ENZYME PRODUCTS

MANUFACTURERS/ SUPPLIERS FOR DIAGNOSTIC ENZYMES

OXIDOREDUCTASES

TABLE 24 LEADING MANUFACTURERS/SUPPLIERS OF OXIDOREDUCTASES

HYDROLASES

TABLE 25 LEADING MANUFACTURERS/SUPPLIERS OF HYDROLASES

TRANSFERASES

TABLE 26 LEADING MANUFACTURERS/SUPPLIERS OF TRANSFERASES

OTHER DIAGNOSTICS (LYASES, LIGASES, AND ISOMERASES)

TABLE 27 LEADING MANUFACTURERS/SUPPLIERS OF LYASES, LIGASES, AND ISOMERASES

MANUFACTURERS/ SUPPLIERS FOR ENZYMES USED IN MOLECULAR RESEARCH

CLEAVING ENZYMES

TABLE 28 LEADING MANUFACTURERS/SUPPLIERS OF LYSOSOMAL ENZYME PRODUCTS

SYNTHESIZING ENZYMES

TABLE 29 LEADING MANUFACTURERS/SUPPLIERS OF SYNTHESIZING ENZYMES

OTHER ENZYMES USED IN RESEARCH

TABLE 30 LEADING MANUFACTURERS/SUPPLIERS OF OTHER ENZYMES USED IN RESEARCH

MARKET SHARES OF INDUSTRY LEADERS

DIGESTIVE ENZYME PRODUCTS /PANCREATIC ENZYME PRODUCTS

TABLE 31 WORLDWIDE MARKET SHARES OF DIGESTIVE ENZYME MANUFACTURERS, 2009 (%)

FIGURE 1 WORLDWIDE MARKET SHARES OF DIGESTIVE ENZYME MANUFACTURERS, 2009 (%)

LYSOSOMAL ENZYME PRODUCTS

TABLE 32 WORLDWIDE MARKET SHARES OF LYSOSOMAL ENZYME MANUFACTURERS, 2009 (%)

FIGURE 2 WORLDWIDE MARKET SHARES OF LYSOSOMAL ENZYME MANUFACTURERS, 2009 (%)

THROMBOLYTIC ENZYME PRODUCTS

TABLE 33 WORLDWIDE MARKET SHARES OF THROMBOLYTIC ENZYME MANUFACTURERS, 2009 (%)

FIGURE 3 WORLDWIDE MARKET SHARES OF THROMBOLYTIC ENZYME MANUFACTURERS, 2009 (%)

OTHER THERAPEUTIC ENZYME PRODUCTS

TABLE 34 WORLDWIDE MARKET SHARES OF THROMBOLYTIC ENZYME MANUFACTURERS, 2009 (%)

FIGURE 4 WORLDWIDE MARKET SHARES OF OTHER ENZYMES MANUFACTURERS, 2009 (%)

OXIDOREDUCTASES

TABLE 35 WORLDWIDE MARKET SHARES OF OXIDOREDUCTASE MANUFACTURERS, 2009 (%)

FIGURE 5 WORLDWIDE MARKET SHARES OF OXIDOREDUCTASE MANUFACTURERS, 2009 (%)

HYDROLASES

TABLE 36 WORLDWIDE MARKET SHARES OF HYDROLASE MANUFACTURERS, 2009 (%)

FIGURE 6 WORLDWIDE MARKET SHARES OF HYDROLASE MANUFACTURERS, 2009 (%)

TRANSFERASES

TABLE 37 WORLDWIDE MARKET SHARES OF TRANSFERASE MANUFACTURERS, 2009 (%)

FIGURE 7 WORLDWIDE MARKET SHARES OF TRANSFERASE MANUFACTURERS, 2009 (%)

OTHERS DIGNOSTIC ENZYMES (LYASES, LIGASES, AND ISOMERASES)

TABLE 38 WORLDWIDE MARKET SHARES OF OTHER DIAGNOSTIC ENZYME MANUFACTURERS, 2009 (%)

FIGURE 8 WORLDWIDE MARKET SHARES OF OTHER DIAGNOSTIC ENZYME MANUFACTURERS, 2009 (%)

CLEAVING ENZYMES

TABLE 39 WORLDWIDE MARKET SHARES OF CLEAVING ENZYME MANUFACTURERS, 2009 (%)

FIGURE 9 WORLDWIDE MARKET SHARES OF CLEAVING ENZYME MANUFACTURERS, 2009 (%)

SYNTHESIZING ENZYMES

TABLE 40 WORLDWIDE MARKET SHARES OF SYNTHESIZING ENZYME MANUFACTURERS, 2009 (%)

FIGURE 10 WORLDWIDE MARKET SHARES OF SYNTHESIZING ENZYME MANUFACTURERS, 2009 (%)

OTHER ENZYMES USED IN RESEARCH

TABLE 41 WORLDWIDE MARKET SHARES OF MANUFACTURERS OF OTHER ENZYMES USED IN RESEARCH, 2009 (%)

FIGURE 11 WORLDWIDE MARKET SHARES OF MANUFACTURERS OF OTHER ENZYMES USED IN RESEARCH, 2009 (%)

CHAPTER SEVEN: NEW DEVELOPMENTS

THERAPEUTIC ENZYMES

TABLE 42 NEW DEVELOPMENTS IN THERAPEUTIC ENZYMES

DIAGNOSTIC ENZYMES

MOLECULAR RESEARCH ENZYMES

CHAPTER EIGHT: MARKET ANALYSIS

TABLE 43 GLOBAL MARKET FOR MEDICAL ENZYMES, THROUGH 2015 ($ MILLIONS)

FIGURE 12 GLOBAL MARKET FOR MEDICAL ENZYMES, THROUGH 2015 ($ MILLIONS)

THERAPEUTIC ENZYMES

TABLE 44 GLOBAL MARKET FOR THERAPEUTIC ENZYMES MARKET BY TYPE, THROUGH 2015 ($ MILLIONS)

FIGURE 13 GLOBAL MARKET FOR THERAPEUTIC ENZYMES MARKET BY TYPE, THROUGH 2015 ($ MILLIONS)

DIGESTIVE ENZYMES

Market Overview

Market Revenue

TABLE 45 WORLDWIDE MARKET FOR DIGESTIVE ENZYMES BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 14 WORLDWIDE MARKET FOR DIGESTIVE ENZYMES BY REGION, THROUGH 2015 ($ MILLIONS)

LYSOSOMAL ENZYMES

Market Overview

Market Revenue

TABLE 46 WORLDWIDE MARKET FOR LYSOSOMAL ENZYME PRODUCTS BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 15 WORLDWIDE MARKET FOR LYSOSOMAL ENZYME PRODUCTS BY REGION, THROUGH 2015 ($ MILLIONS)

THROMBOLYTIC ENZYMES

Market Overview

Market Revenue

TABLE 47 WORLDWIDE MARKET FOR THROMBOLYTIC ENZYME PRODUCTS, BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 16 WORLDWIDE MARKET FOR THROMBOLYTIC ENZYME PRODUCTS, BY REGION, THROUGH 2015 ($ MILLIONS)

OTHER THERAPEUTIC ENZYMES

Market Overview

Market Revenue

TABLE 48 WORLDWIDE MARKET FOR OTHER ENZYME PRODUCTS, BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 17 WORLDWIDE MARKET FOR OTHER ENZYME PRODUCTS BY REGION, THROUGH 2015 ($ MILLIONS)

MARKET SHARES

TABLE 49 WORLDWIDE THERAPEUTIC ENZYME MARKET SHARES, BY REGION, 2009 (%)

FIGURE 18 WORLDWIDE THERAPEUTIC ENZYME MARKET SHARES, BY REGION, 2009 (%)

DIAGNOSTIC ENZYMES

TABLE 50 GLOBAL MARKET FOR DIAGNOSTICS ENZYMES BY TYPE, THROUGH 2015 ($ MILLIONS)

FIGURE 19 GLOBAL MARKET FOR DIAGNOSTICS ENZYMES BY TYPE, 2008-2015 ($ MILLIONS)

OXIDOREDUCTASES

Market Overview

Market Revenue

TABLE 51 WORLDWIDE MARKET FOR OXIDOREDUCTASES BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 20 WORLDWIDE MARKET FOR OXIDOREDUCTASES, BY REGION, 2008-2015 ($ MILLIONS)

HYDROLASES

Market Overview

Market Revenue

TABLE 52 WORLDWIDE MARKET FOR HYDROLASES, BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 21 WORLDWIDE MARKET FOR HYDROLASES, BY REGION, 2008-2015 ($ MILLIONS)

TRANSFERASES

Market Overview

Market Revenue

TABLE 53 WORLDWIDE MARKET FOR TRANSFERASES, BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 22 WORLDWIDE MARKET FOR TRANSFERASES, BY REGION, 2008-2015 ($ MILLIONS)

OTHERS (LYASES, LIGASES, AND ISOMERASES)

Market Overview

Market Revenue

TABLE 54 WORLDWIDE MARKET FOR OTHER ENZYMES (LYASES, LYDASES, AND ISOMERASES), BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 23 WORLDWIDE MARKET FOR OTHER ENZYMES (LYASES, LYDASES, AND ISOMERASES), BY REGION, 2008-2015 ($ MILLIONS)

MARKET SHARES

TABLE 55 WORLDWIDE DIAGNOSTICS ENZYME MARKET SHARES, BY REGION, 2009 (%)

FIGURE 24 WORLDWIDE DIAGNOSTICS ENZYME MARKET SHARES, BY REGION, 2009 (%)

ENZYMES USED FOR MOLECULAR RESEARCH

TABLE 56 GLOBAL MARKET FOR MOLECULAR RESEARCH ENZYMES, BY TYPE, THROUGH 2015 ($ MILLIONS)

FIGURE 25 GLOBAL MARKET FOR MOLECULAR RESEARCH ENZYMES, BY TYPE, THROUGH 2015 ($ MILLIONS)

CLEAVING ENZYMES

Market Overview

Market Revenue

TABLE 57 WORLDWIDE MARKET FOR CLEAVING ENZYMES, BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 26 WORLDWIDE MARKET FOR CLEAVING ENZYMES, BY REGION, THROUGH 2015 ($ MILLIONS)

SYNTHESIZING ENZYMES

Market Overview

Market Revenue

TABLE 58 WORLDWIDE MARKET FOR SYNTHESIZING ENZYMES, BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 27 WORLDWIDE MARKET FOR SYNTHESIZING ENZYMES, BY REGION, 2008-2015 ($ MILLIONS)

OTHER ENZYMES USED IN RESEARCH

Market Overview

Market Revenue

TABLE 59 WORLDWIDE MARKET FOR OTHER ENZYMES USED IN RESEARCH, BY REGION, THROUGH 2015 ($ MILLIONS)

FIGURE 28 WORLDWIDE MARKET FOR OTHER ENZYMES USED IN RESEARCH, BY REGION, 2008-2015 ($ MILLIONS)

MARKET SHARES

TABLE 60 WORLDWIDE ENZYMES USED IN MOLECULAR RESEARCH, MARKET SHARES, BY REGION, 2009

FIGURE 29 WORLDWIDE ENZYMES USED IN MOLECULAR RESEARCH, MARKET SHARES, BY REGION, 2009 (%)

CHAPTER NINE: MARKET BY APPLICATIONS

APPLICATIONS FOR THERAPEUTIC ENZYMES

MARKET REVENUE

TABLE 61 GLOBAL SALES OF THERAPEUTIC ENZYMES, BY APPLICATIONS, THROUGH 2015 ($ MILLIONS)

FIGURE 30 GLOBAL SALES OF THERAPEUTIC ENZYMES, BY APPLICATIONS, THROUGH 2015 ($ MILLIONS)

MARKET OVERVIEW

Cardiovascular Diseases

TABLE 62 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN CARDIOVASCULAR DISEASE MARKET IN 2009 (%)

FIGURE 31 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN CARDIOVASCULAR DISEASE MARKET, 2009 (%)

Cancer and Associated Complications

TABLE 63 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CANCER MARKET, 2009 (%)

FIGURE 32 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CANCER MARKET, 2009 (%)

Pulmonary Embolism

TABLE 64 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE PULMONARY EMBOLISM MARKET, 2009 (%)

FIGURE 33 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE PULMONARY EMBOLISM MARKET, 2009 (%)

Pompe Disease

TABLE 65 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE POMPE DISEASE MARKET, 2009 (%)

FIGURE 34 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN POMPE DISEASE MARKET, 2009 (%)

Fabry Disease

TABLE 66 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE FABRY DISEASE MARKET, 2009 (%)

FIGURE 35 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE FABRY DISEASE MARKET, 2009 (%)

Gaucher's Disease

TABLE 67 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE GAUCHER'S DISEASE MARKET, 2009 (%)

FIGURE 36 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE GAUCHER'S DISEASE MARKET, 2009 (%)

Mucopolysaccharidoses

TABLE 68 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE MUCOPOLYSACCHARIDOSES MARKET, 2009 (%)

FIGURE 37 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE MUCOPOLYSACCHARIDOSES MARKET, 2009 (%)

Cystic Fibrosis and Associated Complications

TABLE 69 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CYSTIC FIBROSIS AND ASSOCIATED DISEASE MARKET, 2009 (%)

FIGURE 38 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CYSTIC FIBROSIS AND ASSOCIATED DISEASE MARKET, 2009 (%)

Other Diseases

TABLE 70 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE OTHER DISEASES MARKET, 2009 (%)

FIGURE 39 WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE OTHER DISEASES MARKET, 2009 (%)

THERAPEUTIC ENZYMES MARKET SHARE BY APPLICATIONS

TABLE 71 WORLDWIDE MARKET SHARE FOR THERAPEUTIC ENZYMES BY APPLICATIONS IN 2009 (%)

FIGURE 40 WORLDWIDE MARKET SHARE FOR THERAPEUTIC ENZYMES BY APPLICATIONS, 2009 (%)

DIAGNOSTIC ENZYMES

TABLE 72 GLOBAL SALES OF DIAGNOSTIC ENZYMES, BY APPLICATIONS, THROUGH 2015 ($ MILLIONS)

FIGURE 41 GLOBAL SALES OF DIAGNOSTIC ENZYMES, BY APPLICATIONS, THROUGH 2015 ($ MILLIONS)

MARKET SHARE OF APPLICATIONS OF DIAGNOSTIC ENZYMES

TABLE 73 WORLDWIDE MARKET SHARE OF DIAGNOSTICS ENZYMES, BY APPLICATION, 2009 (%)

FIGURE 42 WORLDWIDE MARKET SHARE OF DIAGNOSTICS ENZYMES, BY APPLICATION, 2009 (%)

MOLECULAR RESEARCH ENZYMES

TABLE 74 GLOBAL SALES OF MOLECULAR RESEARCH ENZYMES, BY APPLICATIONS, THROUGH 2015 ($ MILLIONS)

FIGURE 43 GLOBAL SALES OF MOLECULAR RESEARCH ENZYMES, BY APPLICATIONS, THROUGH 2015 ($ MILLIONS)

MOLECULAR CLONING

GENOTYPING

SEQUENCING

GENE MAPPING

OTHERS

MARKET SHARES OF MOLECULAR RESEARCH ENZYMES BY APPLICATION

TABLE 75 WORLDWIDE MARKET SHARES FOR MOLECULAR RESEARCH ENZYMES, BY APPLICATION, 2009 (%)

FIGURE 44 WORLDWIDE MARKET SHARES FOR MOLECULAR RESEARCH ENZYMES, BY APPLICATION, 2009 (%)

CHAPTER TEN: PATENT ANALYSIS

PATENTS BY YEAR

TABLE 76 NUMBER OF PATENTS, BY YEAR, 2006-2010

FIGURE 45 NUMBER OF PATENTS BY YEAR, 2006-2010

FIGURE 46 NUMBER OF PATENTS BY YEAR, 2006-2010 (%)

PATENTS BY CATEGORY

TABLE 77 PATENTS BY CATEGORY FOR MEDICINAL ENZYMES, 2006-2010

FIGURE 47 PATENTS BY CATEGORY FOR MEDICINAL ENZYMES AGENTS, 2006-2010

PATENTS BY TYPE

TABLE 78 THERAPEUTIC ENZYME PATENTS BY TYPE, 2006-2010

FIGURE 48 THERAPEUTIC ENZYMES PATENTS BY TYPE, 2006-2010 .... 156

TABLE 79 DIAGNOSTICS ENZYMES PATENTS BY TYPE, 2006-2010

FIGURE 49 DIAGNOSTICS ENZYMES PATENTS BY TYPE, 2006-2010

TABLE 80 RESEARCH ENZYMES PATENTS BY TYPE, 2006-2010

FIGURE 50 RESEARCH ENZYMES PATENTS BY TYPE, 2006-2010

PATENTS BY COMPANY

TABLE 81 NUMBER OF U.S. PATENTS BY COMPANY FOR MEDICINAL ENZYMES, 2006-2010

FIGURE 51 NUMBER OF U.S. PATENTS BY COMPANY FOR MEDICINAL ENZYMES, 2006-2010

PATENTS BY COUNTRY

TABLE 82 NUMBER OF U.S. PATENTS BY COUNTRY FOR MEDICINAL ENZYMES, 2006-2010

FIGURE 52 NUMBER OF U.S. PATENTS BY COUNTRY FOR MEDICINAL ENZYMES, 2006-2010

TABLE 83 PATENT SHARES BY COUNTRY FOR MEDICINAL ENZYMES, 2006-2010 (NUMBER/%)

FIGURE 53 PATENT SHARES BY COUNTRY FOR MEDICINAL ENZYMES, 2006-2010 (%)

PATENTS BY ASSIGNEE

TABLE 84 PATENTS BY TYPE OF ASSIGNEE FOR MEDICINAL ENZYMES, 2006-2010

FIGURE 54 PATENTS BY ASSGINEE TYPE FOR MEDICINAL ENZYMES, 2006-2010

CHAPTER ELEVEN: CURRENT SITUATION

FACTORS AFFECTING ENZYMES MARKET

FDA LAW AND APPROVALS

ORPHAN DRUG DESIGNATION

INCREASED RESEARCH AND DEVELOPMENT AND FUNDS .... 167

MERGERS AND ACQUISITIONS

COLLABORATIONS AND AGREEMENTS

BRAND AND PRICES

MANUFACTURING ISSUES

CHAPTER TWELVE: COMPANY PROFILES

AGILENT TECHNOLOGIES

AMANO ENZYME INC.

AMPHASTAR PHARMACEUTICALS INC.

ASAHI KASEI PHARMA

AUXILIUM PHARMACEUTICALS INC.

AXCAN PHARMA INC.

BBI ENZYMES

BIOCATALYSTS LTD

BIOMARIN PHARMACEUTICALS INC.

BOEHRINGER INGELHEIM GMBH

BIOSPECIFIC TECHNOLOGIES CORP.

CSL BEHRING

DIGESTIVE CARE INC.

EKR THERAPEUTICS

ENZON PHARMACEUTICALS INC.

EURAND N.V.

EUSA PHARM

GE HEALTHCARE LIFE SCIENCES

GENENTECH INC.

GENZYME CORP.

GENZYME DIAGNOSTICS

HALOZYME THERAPEUTICS INC

ISTA PHARMACEUTICALS

LIFE TECHNOLOGIES CORP.

PROMEGA CORP.

PROTALIX BIOTHERAPEUTICS INC.

ROCHE APPLIED SCIENCES

SANOFI-AVENTIS U.S.

SHIRE PLC

SIGMA ALDRICH CORP.

SOLVAY PHARMACEUTICAL INC.

THERMO FISHER SCIENTIFIC, INC.

APPENDIX

ABBREVIATIONS

More Details

To order this report:

: Medical Enzymes: Technologies and Global Markets

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is ... projects are designed, built and brought to market. , The Design Lab is ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
Breaking Biology Technology:
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):